» Articles » PMID: 38740832

An In-silico Modeling Approach to Separate Exogenous and Endogenous Plasma Insulin Appearance, with Application to Inhaled Insulin

Overview
Journal Sci Rep
Specialty Science
Date 2024 May 13
PMID 38740832
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to develop a dynamic model-based approach to separately quantify the exogenous and endogenous contributions to total plasma insulin concentration and to apply it to assess the effects of inhaled-insulin administration on endogenous insulin secretion during a meal test. A three-step dynamic in-silico modeling approach was developed to estimate the two insulin contributions of total plasma insulin in a group of 21 healthy subjects who underwent two equivalent standardized meal tests on separate days, one of which preceded by inhalation of a Technosphere Insulin dose (22U or 20U). In the 30-120 min test interval, the calculated endogenous insulin component showed a divergence in the time course between the test with and without inhaled insulin. Moreover, the supra-basal area-under-the-curve of endogenous insulin in the test with inhaled insulin was significantly lower than that in the test without (2.1 ± 1.7 × 10 pmol·min/L vs 4.2 ± 1.8 × 10 pmol·min/L, p < 0.01). The percentage of exogenous insulin reaching the plasma, relative to the inhaled dose, was 42 ± 21%. The proposed in-silico approach separates exogenous and endogenous insulin contributions to total plasma insulin, provides individual bioavailability estimates, and can be used to assess the effect of inhaled insulin on endogenous insulin secretion during a meal.

Citing Articles

Availability of Open Dynamic Glycemic Data in the Field of Diabetes Research: A Scoping Review.

Del Giudice L, Piersanti A, Gobl C, Burattini L, Tura A, Morettini M J Diabetes Sci Technol. 2025; :19322968251316896.

PMID: 39953711 PMC: 11830157. DOI: 10.1177/19322968251316896.

References
1.
Tura A, Ludvik B, Nolan J, Pacini G, Thomaseth K . Insulin and C-peptide secretion and kinetics in humans: direct and model-based measurements during OGTT. Am J Physiol Endocrinol Metab. 2001; 281(5):E966-74. DOI: 10.1152/ajpendo.2001.281.5.E966. View

2.
Davies M, DAlessio D, Fradkin J, Kernan W, Mathieu C, Mingrone G . Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2018; 41(12):2669-2701. PMC: 6245208. DOI: 10.2337/dci18-0033. View

3.
Miya A, Nakamura A, Handa T, Nomoto H, Kameda H, Cho K . Log-linear relationship between endogenous insulin secretion and glycemic variability in patients with type 2 diabetes on continuous glucose monitoring. Sci Rep. 2021; 11(1):9057. PMC: 8079412. DOI: 10.1038/s41598-021-88749-9. View

4.
Holt R, DeVries J, Hess-Fischl A, Hirsch I, Kirkman M, Klupa T . The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2021; 64(12):2609-2652. PMC: 8481000. DOI: 10.1007/s00125-021-05568-3. View

5.
Argoud G, Schade D, EATON R . Insulin suppresses its own secretion in vivo. Diabetes. 1987; 36(8):959-62. DOI: 10.2337/diab.36.8.959. View